Sapient Therapeutics
Company

Sapient Therapeutics

Biotechnology Research London, City of, United Kingdom 1 employees
Employees
1

Sapient Therapeutics Overview

Headquarters
London, City of, United Kingdom
Website
sapienttx.com
Industry
Biotechnology Research
Employees
1
Founded
2022
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About Sapient Therapeutics

Sapient Therapeutics is a biopharmaceutical company focused on neuroscience drug discovery and early clinical development. Our lead asset (SAP021) has commenced Phase 1 studies and will complete in 2023. Our leadership team is comprised of industry and cannabinoid veterans, most having previously worked together at GW Pharmaceuticals. Together we want to utilise the experience we gained in cannabinoid development and bring new prescription medicines to patients suffering from serious diseases. For more information, please email investorrelations@sapienttx.com or visit: https://sapienttx.com Code: SAP2023TX002 Date of preparation: November 2023

Sapient Therapeutics Contact Details

People in AeroLeads
1

Sapient Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Andrew Saich Chief Medical Officer
View

Compare Similar Companies to Sapient Therapeutics